Nr.NumelestudiuluiStatusLocatia/Locatiilestudiului
1A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced MelanomaIn curs de recrutareLocal Institution, Bucharest, Romania, 022328, Contact: Site 0066         Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0070         Local Institution, Craiova, Romania, 200347, Contact: Site 0067         Local Institution, Lasi, Romania, 700483, Contact: Site 0069
2A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic MelanomaIn curs de recrutareLocal Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0070         Local Institution, Craiova, Romania, 200347, Contact: Site 0071         Local Institution, Floresti, Romania, 407280, Contact: Site 0120         Local Institution, Oradea, Romania, 410469, Contact: Site 0073
3Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma (CheckMate76K)In curs de recrutareLocal Institution, Bucharest, Romania, 020122, Contact: Site 0021         Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0047         Local Institution, Craiova, Romania, 200347, Contact: Site 0020    
4An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma (CheckMate 915)Activ, inca nu se recruteazaInstitute Of Oncology „Prof.Dr.Alexandru Trestioreanu” Bucharest, Bucharest, Romania, 022328Sf. Nectarie Oncology Center, Craiova, Romania, 200347
5Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma (CheckMate 238)Activ, inca nu se recruteazaLocal Institution, Craiova, Romania, 200347Local Institution, Romania, Romania, 400015
6A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete ResectionIn curs de recrutareNova Clin Medical Research Center, Timisoara, Romania, 300696, Contact: Alexandru Bolocan, Site 0030   
7Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)In curs de recrutareSpitalul Universitar CF Cluj-Napoca ( Site 1103)        RecruitingCluj-Napoca, Cluj, Romania, 400015, Contact: Study Coordinator    +40724283983      S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1101), Craiova, Dolj, Romania, 200347, Contact: Study Coordinator    +40727774974      S C Oncocenter Oncologie Medicala S R L (Site 1106), Timisoara, Timis, Romania, 300166, Contact: Study Coordinator    +40745146020      Hifu Terramed Conformal SRL ( Site 1111), Bucharest, Romania, 031864, Contact: Study Coordinator    +40723599588      S.C.Focus Lab Plus S.R.L ( Site 1107), Bucuresti, Romania, 021389, Contact: Study Coordinator    +40721298677      Cardiomed SRL Cluj-Napoca ( Site 1104), Cluj-Napoca, Romania, 400015, Contact: Study Coordinator    +40724543672      S C Pelican Impex SRL ( Site 1108), Oradea, Romania, 410450, Contact: Study Coordinator    +40746103306      Policlinica Oncomed SRL ( Site 1105), Timisoara, Romania, 300239, Contact: Study Coordinator    +40744571617     
8A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)Activ, inca nu se recruteazaCentrul de Oncologie Sfantul Nectarie, Craiova, Dolj, Romania, 200347Oncolab SRL, Craiova, Dolj, Romania, 200385Medisprof SRL , Cluj-Napoca, Romania, 400461Clinical Emergency Hospital of Constanta, Constanta, Romania, 900591Center of Oncology Euroclinic, Iasi, Romania, 700106Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu, Romania, 550245Oncocenter – Oncologie Clinica SRL, Timisoara, Romania, 300166
(Visited 6 times, 1 visits today)